Zenas BioPharma, Inc.
Status: Publicly traded
Direct answer
Zenas BioPharma, Inc. is publicly traded on NASDAQ under the ticker ZBIO.
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and...
Can you invest in Zenas BioPharma, Inc.?
Yes. Zenas BioPharma, Inc. trades publicly on NASDAQ as ZBIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zenas BioPharma, Inc.
Detailed equity research is provided by MarketSnap.